Navigation Links
arGEN-X Concludes EUR 12.5 Million Series A Financing Round
Date:12/3/2009

generate an optimal lead diversity.

Philippe Guinot, PhD, Senior Partner at Credit Agricole Private Equity commented: "We believe that arGEN-X has a truly innovative technology and a management team with an impressive track record of building a valuable business in the antibody area. It is no surprise to us that the Company was able to attract such a high-quality syndicate of investors for its Series A round and Credit Agricole Private Equity is delighted to have had this opportunity to participate at this important early stage of the arGEN-X' development."

Tim Van Hauwermeiren, Chief Executive Officer of arGEN-X added: "We are very pleased to have raised this additional funding from two experienced European life science investors. In addition, we are proud to become VIB's first external investment and we view this as a real quality stamp of approval. With substantial funding now in place, arGEN-X is well positioned to execute its ambitious value-creating strategy over the next two years."

Notes for the editor

About arGEN-X - http://www.arGEN-X.com

arGEN-X is a research stage biopharmaceutical company with a broadly applicable, proprietary SIMPLE Antibody(TM) platform. The platform allows arGEN-X to create an unparalleled diversity of in vivo generated antibody leads against a broad range of human disease targets. This superior choice of ultra-high affinity and highly potent leads, having best-in-class human homology, allows for more stringent lead selection criteria, thereby increasing the probability of success later in the drug development path. The Company has validated its monoclonal antibody platform on two human disease targets and has broad patent claims in place covering its technology.

arGEN-X(TM) and SIMPLE Antibody(TM) are deposited trademarks of arGEN-X BV.

SIMPLE stands for Superior Immuno
'/>"/>

SOURCE arGEN-X
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Phase IV Multi-center Clinical Study of Kutai Concludes in Nanjing
2. Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
3. Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
4. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
5. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
6. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
7. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
8. Russias Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013
9. For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult
10. Vermillion Files Plan of Reorganization
11. Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... WOONSOCKET, R.I. , Aug. 28, 2014  In ... of developing health complications from the flu, pneumonia, ... MinuteClinic ® have declared September to be ... as they age, it is important that adults ... date on their vaccinations. CVS pharmacists and MinuteClinic ...
(Date:8/28/2014)... ROCK, Colo. , Aug. 28, 2014   ... diagnostic company focused on obtaining FDA clearance for and ... rapid blood test for aiding in identifying children, adolescent, ... are at low risk for appendicitis, today announced it ... & Renshaw 16 th Annual Global Investment Conference ...
(Date:8/28/2014)... 28, 2014  Stryker Orthopaedics, the Official Joint Replacement Products ... message of joint health to golf fans at the next ... Deutsche Bank Championship. The company,s fan destination – "The Stryker ... on 9" at the TPC Boston in Norton, ...    At the Deutsche Bank Championship, Stryker will ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
... Aug. 3, 2011 Reportlinker.com ... research report is available in ... Canada Orthopedic Devices Market Outlook ... Spinal Surgery, Orthobiologics, Trauma Fixation ...
... 2011 Grifols, a global healthcare company and ... the structure of its new North American Commercial ... U.S. commercial group will be organized by product ... North America.  The Canadian organization, a major presence ...
Cached Medicine Technology:Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 2Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 3Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 4Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 5Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 6Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 7Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 8Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 9Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 10Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 11Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 12Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 13Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 14Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 15Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 16Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 17Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 18Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 19Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 20Grifols Announces New North American Commercial Operations Organization 2Grifols Announces New North American Commercial Operations Organization 3
(Date:8/28/2014)... Manchester scientists are working out how to safely increase ... potentially offering improved local control and survival. , Standard ... a combination of radiotherapy and chemotherapy. Traditionally this is ... may not always be enough to stop tumour growth. ... the cancerous tissue varies between patients and depends on ...
(Date:8/28/2014)... York (PRWEB) August 28, 2014 Vaccine ... perceived with great interest among other healthcare industry sectors ... the high demand in vaccine with respect to evolving ... in demand due to an improved understanding for a ... the United States. It has led to new opportunities ...
(Date:8/28/2014)... 2014 AmeriPride Services, a leading textile ... the launch of its new Customer Portal, an online ... and more convenient for customers. The industry-leading digital tool ... communicate with the company. , Features of the new ... Access, download and pay bills online , ...
(Date:8/28/2014)... After more than two years of ... excited to announce the opening of Houston’s Mirror Mirror ... city, Mirror Mirror Beauty Boutique offers premium aesthetic services ... corner of Richmond and Drexel near Highland Village, Mirror ... cutting-edge technology in a private, easy to access location. ...
(Date:8/28/2014)... Hastings and Hastings is a Phoenix personal injury ... services and other legal services in Arizona for over ... it has saved a client more than $23,000 related ... half of a million dollars. This is concrete proof ... that result in real savings for clients. Measured in ...
Breaking Medicine News(10 mins):Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $23,400 On Settlement Of $540,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $23,400 On Settlement Of $540,000 3
... the malaria parasites to attack the red blood cells. ... Cell, will help the scientists in designing vaccines against ... through which malaria parasites invade red blood cells is ... merozoites called EBA-175 to a receptor protein on the ...
... a smart bomb for cancer treatment is to be reported ... into the tumor, seal the opening and then deliver ... This will leave the healthy cells unharmed. ,The ... cancer have the potential of being a revolutionary form of ...
... those people suffering from tension-headaches, acupuncture may be the ... journal BMJ said that acupuncture can reduce the incidence ... - the gold standard of clinical trials - researchers ... of tension headache into three groups. ,Over ...
... delays healing of physical wounds, a new study says//. ... of Illinois at Chicago in a study of laboratory ... delayed the closing of wounds by more than 45 ... of cell and genetic changes accounted for the slow ...
... and happen even when people are not aware of their ... 2005 issue of Nature. ,Researchers from University of California, ... Affairs Health System had undertaken the study to find out ... when they are actually not aware of doing so. ...
... A new study by scientists in Japan may help ... UPI. ,Richard Smith, a research professor in otolaryngology ... University gave a genetically deafened mouse interfering RNA (Ribonucleic ... that would otherwise cause deafness. ,"By preventing its ...
Cached Medicine News:Health News:Researchers Discover Protein That Causes Malaria 2Health News:An Anti-cancer Smart Bomb delivered using a Nanocell 2Health News:An Anti-cancer Smart Bomb delivered using a Nanocell 3Health News:Acupuncture May Be An Effective Treatment Against Tension-Headaches 2Health News:Habit Memory May Enhance Learning In People 2
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
Medicine Products: